Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
02/2012
02/22/2012CN101721435B 一种灵芝孢子粉纳米硒复合物及其制备方法 One kind of fungus spores on nano selenium compound and preparation method
02/22/2012CN101716318B 一种用于辅助化疗方式治疗消化系统肿瘤的中药制剂 An adjuvant chemotherapy Chinese medicine for the treatment of digestive tumors way
02/22/2012CN101716237B 一种治疗由轮状病毒所致的婴幼儿腹泻的中药组合物 A treatment caused by rotavirus diarrhea in infants and young children herbal composition
02/22/2012CN101708322B 治疗风湿疾病的药酒 Treatment of rheumatoid diseases wine
02/22/2012CN101683354B 一种肝损伤相关的药物靶点及其应用 One kind of liver injury associated with drug targets and its application
02/22/2012CN101669950B 苦豆碱在制备治疗溃疡性结肠炎药物中的应用 Aloperine in the manufacture of a medicament for the treatment of ulcerative colitis
02/22/2012CN101612193B 一种用于治疗胆囊炎、胆管炎的药物组合物 A pharmaceutical composition for the treatment of cholecystitis, cholangitis
02/22/2012CN101574348B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method
02/22/2012CN101549077B 用于综合治疗小儿腹泻的中药制剂 For the comprehensive treatment of infantile diarrhea Chinese medicine
02/22/2012CN101361901B 一种保健葡萄酒 A health wine
02/22/2012CN101152307B 一种用于治疗腹痛、腹泻的中药软胶囊及其制备方法 A method for the treatment of abdominal pain, diarrhea medicine soft capsule and its preparation method
02/22/2012CN101002801B 一种增强免疫力的保健食品的制备方法 A method of preparing a health food to enhance immunity
02/21/2012US8119697 Anti-nausea and anti-vomiting activity of cannabidiol compounds
02/21/2012US8119687 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
02/21/2012US8119665 Aryl imidazoles and related compounds as C5a receptor modulators
02/21/2012US8119604 Polypeptide formulation
02/21/2012US8119405 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
02/21/2012US8119397 Therapeutic agents and therapeutic methods for treating injured tissue
02/21/2012US8119141 Cinnamomi and poria composition, method to prepare same and uses thereof
02/21/2012US8119121 Delivering a concentrated amount of stem cells obtained from adipose tissue to a patient
02/21/2012CA2682254C 1,3-oxathiolane nucleoside analogues
02/21/2012CA2633077C Solid-state form of amg 706 and pharmaceutical compositions thereof
02/21/2012CA2503215C Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist
02/21/2012CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors
02/21/2012CA2483908C Vascularization enhanced graft constructs
02/21/2012CA2451981C 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
02/21/2012CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
02/21/2012CA2400141C Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
02/16/2012WO2012021133A1 Synthetic bile acid compositions and methods
02/16/2012WO2012020821A1 Prophylactic or therapeutic agent for non-alcoholic steatohepatitis
02/16/2012WO2012020785A1 Medicinal agent for prevention and/or treatment of hepatocellular carcinoma
02/16/2012WO2012020767A1 Pyrroloquinoline quinone gel
02/16/2012WO2012020762A1 Hetero ring compound
02/16/2012WO2012020757A1 Production method for cell populations
02/16/2012WO2012020376A1 Peg for the treatment of functional abdominal pains
02/16/2012WO2012020279A1 Product for the upper gastric sphere
02/16/2012WO2012020235A1 Treatment
02/16/2012WO2012019930A1 Method for treating fatty liver diseases, in particular non-alcoholic steatohepatitis.
02/16/2012WO2012019533A1 Electronic cigarette's atomization composition with calcium pectate gel and preparation process and use thereof
02/16/2012WO2012019432A1 Use of reg4 and pharmaceutical composition thereof
02/16/2012WO2012019428A1 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof
02/16/2012WO2012019255A1 The use of a plant extract, pharmaceutical compositions thereof, and use of said pharmaceutical compositions
02/16/2012US20120041082 Methods of using smad3 and jak2 genetic variants to diagnose and predict inflammatory bowel disease
02/16/2012US20120041054 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction
02/16/2012US20120041045 Use of pharmaceutical compositions containing mesembrenone
02/16/2012US20120041031 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
02/16/2012US20120041030 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
02/16/2012US20120041024 Quinolyl amines as kinase inhibitors
02/16/2012US20120041021 Process for Preparing a Semi-Solid Delivery Vehicle and Pharmaceutical Compositions
02/16/2012US20120041020 Methods of Treatment Utilizing Semi-Solid Pharmaceutical Compositions
02/16/2012US20120041008 4-Phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-Based Compounds and Methods of Their Use
02/16/2012US20120041004 Fused pyrimidine-dione derivatives as trpai modulators
02/16/2012US20120041003 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
02/16/2012US20120040997 Vinyl-aryl derivatives for inflammation and immune-related uses
02/16/2012US20120040990 Indol-3-y-carbonyl-piperidin and piperazin-derivatives
02/16/2012US20120040984 Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof
02/16/2012US20120040983 Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
02/16/2012US20120040961 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
02/16/2012US20120040956 Inhibitors of hif-1 protein accumulation
02/16/2012US20120040952 Azetidines as histamine h3 receptor antagonists
02/16/2012US20120040951 Heteroaryl compounds useful as raf kinase inhibitors
02/16/2012US20120040941 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
02/16/2012US20120040935 Compositions useful as inhibitors of voltage-gated ion channels
02/16/2012US20120040934 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
02/16/2012US20120040933 9-(piperazinylalkyl) carbazoles as bax-modulators
02/16/2012US20120040923 Stable s-adenosyl-l-methionine
02/16/2012US20120040897 Novel derivatives of acyl cyanopyrrolidines
02/16/2012US20120040892 Methods and Compositions for the Treatment of Heart Failure and Other Disorders
02/16/2012US20120040886 Analogues of Neuropeptide Y Having Proline Substitution At Position 34
02/16/2012US20120040031 Compositions comprising lipophilic extracts of zingiber officinale and echinacea angustifolia for the prevention and treatment of gastro-oesophageal reflux and chemotherapy-induced emesis
02/16/2012US20120040020 Compounds useful as inhibitors of atr kinase
02/16/2012US20120040014 LIPID Supplements for Maintaining Health and Treatment of Acute and Chronic Disorders
02/16/2012US20120040012 Therapeutic stem cell nutrient composition and uses thereof
02/16/2012US20120039998 Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
02/16/2012US20120039949 Stable Solid Formulations of GC-C Receptor Agonist Polypeptides Suitable for Oral Administration
02/16/2012US20120039936 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
02/16/2012US20120039928 Medicinal plants extract using processing of herbal medicine and composition of skin external application comprising the same
02/16/2012US20120039924 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
02/16/2012US20120039913 Selective Histamine H4 Receptor Antagonists for the Treatment of Vestibular Disorders
02/16/2012US20120039911 Cd93 or use of soluble fragment thereof
02/16/2012US20120039902 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
02/16/2012US20120039873 Antibodies against monocyte chemotactic proteins
02/16/2012US20120039860 Compositions and methods for improved oral health
02/16/2012US20120039841 T-Helper Cell Type 17 Lineage-Specific Adjuvants, Compositions and Methods
02/16/2012CA2844474A1 Probiotic liquid food products
02/16/2012CA2808435A1 Heterocyclic compound
02/16/2012CA2808091A1 Stable formulations of linaclotide
02/16/2012CA2808039A1 Prophylactic or therapeutic agent for non-alcoholic steatohepatitis
02/16/2012CA2783017A1 Synthetic bile acid compositions and methods
02/15/2012EP2418208A1 Inhibitor for elevation of gip level
02/15/2012EP2417986A1 Bioactive compositions
02/15/2012EP2416771A2 Methods and compositions of pi-3 kinase inhibitors for treating fibrosis
02/15/2012EP1797077B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
02/15/2012EP1381432B1 HSA-free formulations of interferon-beta
02/15/2012CN102352324A Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
02/15/2012CN102351967A High-molecular material containing cholic acid and liver-targeting drug delivery nanoparticle modified by same
02/15/2012CN102351959A Preparation method and application of multiflower knotweed vine polysaccharide chelate zinc
02/15/2012CN102351918A Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
02/15/2012CN102351881A Stable levofloxacin hydrochloride compound
02/15/2012CN102351880A Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 1258